David Hardwicke
Investment Consultant at Pathway Bioventures
About
Biotechnology professional with a background in technology commercialization, program management, and drug development, with prior roles at Novartis Gene Therapies and ONK Therapeutics. Works with Pathway on new investment opportunities in gene editing, RNA therapeutics, and cancer therapies.